These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 22507644

  • 1. Human papillomavirus and gene mutations in head and neck squamous carcinomas.
    Friedland P, Thomas A, Naran A, Amanuel B, Grieu-Iacopetta F, Carrello A, Harnett G, Meyer C, Phillips M.
    ANZ J Surg; 2012 May; 82(5):362-6. PubMed ID: 22507644
    [Abstract] [Full Text] [Related]

  • 2. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES, Urban K, Stiegler S, Müller M, Kloor M, Mai S, Ottstadt M, Lohr F, Wenz F, Wagner S, Wittekindt C, Klussmann JP, Hampl M, von Knebel Doeberitz M, Reuschenbach M.
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [Abstract] [Full Text] [Related]

  • 3. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T, Yamamoto H, Nakashima T, Nishijima T, Satoh M, Hatanaka Y, Shiratsuchi H, Yasumatsu R, Toh S, Komune S, Oda Y.
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [Abstract] [Full Text] [Related]

  • 4. Molecular and IHC analysis of head and neck carcinomas associated with HPV infection.
    Stanek L, Glendova K, Tesarova P, Gurlich R, Holeckova P, Musil Z, Hrudka J, Pala M, Mateicka F, Chovanec M.
    Bratisl Lek Listy; 2019 Apr; 120(11):832-838. PubMed ID: 31747763
    [Abstract] [Full Text] [Related]

  • 5. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, Ferris RL, Carey TE, Myers JN, Pickering CR, Head and Neck Cancer Specialized Program of Research Excellence (SPORE) Human Immunodeficiency Virus (HIV) Supplement Consortium.
    Cancer; 2018 Jan 01; 124(1):84-94. PubMed ID: 29053175
    [Abstract] [Full Text] [Related]

  • 6. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T, Pectasides E, Prasad M, Sasaki C, Gouveris P, Dimou A, Kountourakis P, Perisanidis C, Burtness B, Zaramboukas T, Rimm D, Fountzilas G, Psyrri A.
    Ann Oncol; 2013 Aug 01; 24(8):2124-31. PubMed ID: 23406730
    [Abstract] [Full Text] [Related]

  • 7. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM.
    Clin Cancer Res; 2008 Jan 15; 14(2):366-9. PubMed ID: 18223210
    [Abstract] [Full Text] [Related]

  • 8. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ, Urban D, Angel C, Corry J, Lyons B, Vallance N, Kleid S, Iseli TA, Solomon B, Rischin D.
    Br J Cancer; 2015 Mar 17; 112(6):1098-104. PubMed ID: 25688737
    [Abstract] [Full Text] [Related]

  • 9. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?
    Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Eckel HE, Pfister HJ, Fuchs PG.
    Med Microbiol Immunol; 2003 Aug 17; 192(3):129-32. PubMed ID: 12920586
    [Abstract] [Full Text] [Related]

  • 10. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M, Sewell A, Kaech S, Burtness B, Yarbrough WG, Issaeva N.
    Cancer; 2017 May 15; 123(10):1778-1790. PubMed ID: 28295222
    [Abstract] [Full Text] [Related]

  • 11. Human papillomavirus type 16 in head and neck carcinogenesis.
    Chen R, Aaltonen LM, Vaheri A.
    Rev Med Virol; 2005 May 15; 15(6):351-63. PubMed ID: 15942978
    [Abstract] [Full Text] [Related]

  • 12. North-American survey on HPV-DNA and p16 testing for head and neck squamous cell carcinoma.
    Maniakas A, Moubayed SP, Ayad T, Guertin L, Nguyen-Tan PF, Gologan O, Soulieres D, Christopoulos A.
    Oral Oncol; 2014 Oct 15; 50(10):942-6. PubMed ID: 25096827
    [Abstract] [Full Text] [Related]

  • 13. Is biomarker research advancing in the era of personalized medicine for head and neck cancer?
    Yokota T.
    Int J Clin Oncol; 2014 Apr 15; 19(2):211-9. PubMed ID: 24442754
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
    Szabó B, Nelhubel GA, Kárpáti A, Kenessey I, Jóri B, Székely C, Peták I, Lotz G, Hegedus Z, Hegedus B, Füle T, Döme B, Tímár J, Tóvári J.
    Oral Oncol; 2011 Jun 15; 47(6):487-96. PubMed ID: 21498106
    [Abstract] [Full Text] [Related]

  • 15. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker?
    Hoffmann M, Tribius S, Quabius ES, Henry H, Pfannenschmidt S, Burkhardt C, Görögh T, Halec G, Hoffmann AS, Kahn T, Röcken C, Haag J, Waterboer T, Schmitt M.
    Cancer Lett; 2012 Oct 01; 323(1):88-96. PubMed ID: 22484467
    [Abstract] [Full Text] [Related]

  • 16. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I, Budach V, Saki M, Konschak R, Niehr F, Jöhrens K, Weichert W, Linge A, Lohaus F, Krause M, Neumann K, Endris V, Sak A, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Baumann M, DKTK-ROG.
    Eur J Cancer; 2016 Apr 01; 57():78-86. PubMed ID: 26896955
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
    van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ.
    Int J Cancer; 2012 Apr 15; 130(8):1806-12. PubMed ID: 21607949
    [Abstract] [Full Text] [Related]

  • 18. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients.
    Mazurek AM, Rutkowski T, Fiszer-Kierzkowska A, Małusecka E, Składowski K.
    Oral Oncol; 2016 Mar 15; 54():36-41. PubMed ID: 26786940
    [Abstract] [Full Text] [Related]

  • 19. p16, p53 and EGFR expression in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters.
    Gupta S, Pandey P, Verma S, Verma A.
    J Cancer Res Ther; 2024 Apr 01; 20(3):881-887. PubMed ID: 39023595
    [Abstract] [Full Text] [Related]

  • 20. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
    Alsahafi EN, Thavaraj S, Sarvestani N, Novoplansky O, Elkabets M, Ayaz B, Tavassoli M, Legends MF.
    Cancer Lett; 2021 Feb 01; 498():80-97. PubMed ID: 33137407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.